Navigation Links
Align Technology Names Dana C. Cambra as VP, Research & Development
Date:5/19/2008

SANTA CLARA, Calif., May 19 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN), today announced that it has hired Dana C. Cambra as vice president of research and development, effective June 16. Mr. Cambra will report directly to Align President and Chief Executive Officer, Thomas M. Prescott and lead the Company's research and development initiatives.

"Product innovation is Align's highest priority and we are pleased to have Dana on board to lead the team responsible for developing and executing our research initiatives and product roadmap," said Thomas M. Prescott, Align president and CEO. "Dana's extensive experience in medical technology and software development will be of tremendous value to Align as we continue our history of innovation and build the next generation of Invisalign products."

Innovation has been a hallmark of Mr. Cambra's career. As a member of the management and technical teams at Acuson Corporation, now a Siemens Company, he was instrumental in the development of the Sequoia Medical Diagnostic Ultrasound system, a breakthrough in high-resolution ultrasound products that has generated more than $4 billion in revenue.

More recently, Mr. Cambra served as senior vice president, research and development for Pharsight Corporation, a leading provider of simulation and modeling software for pharmaceutical and biotechnology companies. Prior to his role at Pharsight, Mr. Cambra was vice president, engineering at Stentor Inc. and the Phillips Global PACS business unit, an industry leader in providing medical informatics solutions. Earlier roles included senior engineering and operations positions at Visto, where he led development of communications solutions for the first Handspring/Palm Treo device, and iScribe, where he led the development of an industry leading ePrescribing solution.

Mr. Cambra received his undergraduate degrees in mathematics and engineering from MIT and his graduate degree in engineering from UC Berkeley.

About Align Technology, Inc.

Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and older teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998.

To learn more about Invisalign or to find a certified Invisalign doctor in your area, please visit http://www.invisalign.com or call 1-800-INVISIBLE.

Investor Relations Contact Press Contact

Shirley Stacy Shannon Mangum Henderson

Align Technology, Inc. Ethos Communication, Inc.

(408) 470-1150 (678) 540-9222

sstacy@aligntech.com align@ethoscommunication.com


'/>"/>
SOURCE Align Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. US Oncology Applauds Journal of Clinical Oncology Study Highlighting Value of PET Scans for Cancer Patients With Various Types of Malignancies
2. NUCRYST Announces Management Realignment and R&D Portfolio Change
3. New regulatory circuit identified for aggressive, malignant brain tumor
4. Malignant tumor or benign cyst?
5. Is Cancer Community in Alignment About Cure and Costs? NCCN Conference Panel Asks
6. Protein in Human Embryonic Stem Cells Controls Malignant Tumor Cells
7. Protein in embryonic stem cells control malignant tumor cells
8. ULLICO Casualty Group Aligns with Hudson Insurance Company to Offer Fiduciary and Union Liability Insurance
9. Alessi Skin Care Aligns With Celebrity Socialite Fabian Basabe to Raise Awareness for Their Face Forward Campaign
10. InterComponentWare Inc. Aligns with the Center for Health Transformation
11. Align Technology Executives to Present at Upcoming Financial Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... PA (PRWEB) , ... December 09, 2016 , ... "I ... Fla. "I used this old family recipe, which is meant to relieve gout and ... it gave me a 12-hour energy boost every time. It relieved what VA doctors ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy ... in New York, NY, on December 3rd, to benefit Holy Name Medical Center's ... annual event, which raised over $1 million - the largest event in the ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Florida Hospital ... and Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric medicine. This accreditation ... a few hospitals and facilities have earned this distinction. This is the second ...
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation ... adherence, and other pharmacist-delivered patient care services, has announced the promotions of Karen ... to vice president of sales. , Litsinger joined Mirixa in 2008 after ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView ... customers and employees that are both engaging and easy to use. Coming off ... the software company revealed today its plans to roll out new AI-powered self-service ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Fla. , Dec. 9, 2016  Harmar Mobility, LLC announced ... and a member of the Board of Directors. Photo ... ... Mr. Dawson,s ... development of organizations across a variety of industries. He brings to ...
(Date:12/9/2016)... -- Research and Markets has announced the addition of ... offering. ... global travel vaccines market to grow at a CAGR of 6.83% ... scenario and the growth prospects of the global travel vaccines market ... revenue generated from the sales of various vaccines administered to actively ...
(Date:12/8/2016)... -- IRIDEX Corporation (NASDAQ: IRIX ) today announced ... stock, $0.01 par value (the "Offering" with such shares being ... terms of the Offering will depend on market and other ... no assurance as to whether or when the Offering may ... proceeds it will receive from this offering for working capital ...
Breaking Medicine Technology: